BioVentures Investors

Summary

The main office of represented VC is situated in the Wellesley. The venture was found in North America in United States.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Bioventures Investors, startups are often financed by DSM Venturing, BASF Venture Capital, Techno Venture Management. The meaningful sponsors for the fund in investment in the same round are Lilly Ventures, Oxford Bioscience Partners, Advanced Technology Ventures. In the next rounds fund is usually obtained by Lilly Ventures, Polaris Partners, Oxford Bioscience Partners.

We can highlight the next thriving fund investment areas, such as Biotechnology, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Biolex Therapeutics, Ardais Corporation, Verax Biomedical. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Bioventures Investors performs on 6 percentage points less the average number of lead investments. The top amount of exits for fund were in 2005. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year.

The fund was created by Marc Goldberg. Besides them, we counted 6 critical employees of this fund in our database.